hsa-mir-6826-3p _LIHC.png
hsa-mir-6751-3p _LIHC.png
hsa-mir-4659a-3p _LIHC.png
hsa-mir-4753-3p _LIHC.png
hsa-mir-548ar-3p _LIHC.png
hsa-mir-892b _LIHC.png
ABI2 _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10002235
Fusion event
HBV-ABI2 integration
Validated
No
Detection method
HIVID
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2016
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
Host Sequence
Chromosome
chr2
Cytoband
q33.2
Reference genome
End
204210287/203345564 (Hg38)
Location type
Intronic
Fragile sites / regions
Target gene
miRNAs that regulate target gene
hsa-mir-193b-3p ; hsa-mir-331-3p ; hsa-mir-375 ; hsa-mir-1224-5p ; hsa-mir-30c-5p ; hsa-mir-17-5p ; hsa-mir-155-5p ; hsa-mir-136-5p ; hsa-mir-192-3p ; hsa-mir-6786-3p ; hsa-mir-365b-3p ; hsa-mir-365a-3p ; hsa-mir-599 ; hsa-mir-5582-3p ; hsa-mir-3161 ; hsa-mir-548f-3p ; hsa-mir-548e-3p ; hsa-mir-548az-3p ; hsa-mir-548ar-3p ; hsa-mir-548a-3p ; hsa-mir-3127-5p ; hsa-mir-6740-3p ; hsa-mir-6754-5p ; hsa-mir-4441 ; hsa-mir-4270 ; hsa-mir-211-3p ; hsa-mir-9500 ; hsa-mir-3187-3p ; hsa-mir-4529-5p ; hsa-mir-3190-5p ; hsa-mir-892b ; hsa-mir-193a-3p ; hsa-mir-429 ; hsa-mir-200c-3p ; hsa-mir-200b-3p ; hsa-mir-8084 ; hsa-mir-5583-5p ; hsa-mir-3129-3p ; hsa-mir-620 ; hsa-mir-1277-5p ; hsa-mir-190a-3p ; hsa-mir-5011-5p ; hsa-mir-297 ; hsa-mir-3924 ; hsa-mir-223-5p ; hsa-mir-567 ; hsa-mir-511-3p ; hsa-mir-3976 ; hsa-mir-5580-3p ; hsa-mir-574-5p ; hsa-mir-6867-5p ; hsa-mir-3177-5p ; hsa-mir-4267 ; hsa-let-7g-3p ; hsa-let-7a-2-3p ; hsa-mir-4302 ; hsa-mir-6856-5p ; hsa-mir-6758-5p ; hsa-mir-2681-5p ; hsa-mir-432-3p ; hsa-mir-6826-3p ; hsa-mir-1193 ; hsa-mir-8069 ; hsa-mir-4308 ; hsa-mir-6801-3p ; hsa-mir-6810-3p ; hsa-mir-888-5p ; hsa-mir-6751-3p ; hsa-mir-6809-3p ; hsa-mir-4753-3p ; hsa-mir-130b-5p ; hsa-mir-6769b-3p ; hsa-mir-4723-3p ; hsa-mir-3183 ; hsa-mir-6849-3p ; hsa-mir-6877-3p ; hsa-mir-6819-3p ; hsa-mir-1236-3p ; hsa-mir-4659b-3p ; hsa-mir-4659a-3p ; hsa-mir-6875-3p ; hsa-mir-4778-3p ; hsa-mir-1178-3p ; hsa-mir-502-5p ; hsa-mir-1260b ; hsa-mir-1260a ; hsa-mir-3934-3p ; hsa-mir-532-3p ; hsa-mir-1915-5p ; hsa-mir-6841-3p ; hsa-mir-1224-3p ; hsa-mir-3937 ; hsa-mir-7853-5p ; hsa-mir-105-5p ; hsa-mir-3658 ; hsa-mir-3653-3p ; hsa-mir-6513-5p ; hsa-mir-887-5p ; hsa-mir-3913-5p ; hsa-mir-3122 ; hsa-mir-450a-1-3p ; hsa-mir-6780a-5p ; hsa-mir-6779-5p ; hsa-mir-3689c ; hsa-mir-3689b-3p ; hsa-mir-3689a-3p ; hsa-mir-30b-3p ; hsa-mir-1273h-5p ; hsa-mir-6788-5p ; hsa-mir-30c-2-3p ; hsa-mir-30c-1-3p ; hsa-mir-6748-5p ; hsa-mir-6769b-5p ; hsa-mir-6769a-5p ; hsa-mir-3165 ; hsa-mir-4483 ; hsa-mir-1293 ; hsa-mir-6766-5p ; hsa-mir-6756-5p ; hsa-mir-6745 ; hsa-mir-363-5p ; hsa-mir-6799-5p ; hsa-mir-6883-5p ; hsa-mir-6785-5p ; hsa-mir-4728-5p ; hsa-mir-149-3p ; hsa-mir-7106-5p ; hsa-mir-381-5p ; hsa-mir-6134 ; hsa-mir-6089 ; hsa-mir-383-3p ; hsa-mir-5089-5p ; hsa-mir-7151-3p ; hsa-mir-5095 ; hsa-mir-5589-5p ; hsa-mir-4731-5p ; hsa-mir-6506-5p ; hsa-mir-619-5p ; hsa-mir-6504-3p ; hsa-mir-512-3p ; hsa-mir-4438 ; hsa-mir-520e ; hsa-mir-520d-3p ; hsa-mir-520c-3p ; hsa-mir-520b ; hsa-mir-520a-3p ; hsa-mir-373-3p ; hsa-mir-372-3p ; hsa-mir-302e ; hsa-mir-302d-3p ; hsa-mir-302c-3p ; hsa-mir-302b-3p ; hsa-mir-302a-3p ; hsa-mir-93-5p ; hsa-mir-526b-3p ; hsa-mir-519d-3p ; hsa-mir-20b-5p ; hsa-mir-20a-5p ; hsa-mir-106b-5p ; hsa-mir-106a-5p ; hsa-mir-3152-5p ; hsa-mir-4774-3p ; hsa-mir-24-2-5p ; hsa-mir-24-1-5p ; hsa-mir-338-5p ; hsa-mir-6796-3p ; hsa-mir-99b-3p ; hsa-mir-99a-3p ; hsa-mir-4769-5p ; hsa-mir-4654 ; hsa-mir-6778-5p ; hsa-mir-1233-5p ; hsa-mir-4648 ; hsa-mir-8059 ; hsa-mir-4471 ; hsa-mir-1292-5p ; hsa-mir-134-3p ; hsa-mir-1-3p ; hsa-mir-206 ; hsa-mir-361-5p ; hsa-mir-3652 ; hsa-mir-374a-3p ; hsa-mir-4430 ; hsa-mir-4694-5p ; hsa-mir-6128 ; hsa-mir-613 ; hsa-mir-6499-3p ; hsa-mir-6879-3p
Nearest miRNA
hsa-mir-10b/Upstream/14212453; hsa-mir-1244-1/Downstream/3437670;
Nearest cancer related gene
ABI2(TSG, No orient, 0)
Upstream sequence
tccggacacaatcttagctcactgcaatctccacctcctgggttcaagcgattctcctgcctcagcctcctgagtagctgggacaacaggtgcccgccac
Downstream sequence
catgccagctaatttggtatttttagtagagatggggtttcaccgtcttggccagtctggtctcgaactcctgacttcaggtgatccacccacctcggcc
Reference
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.
Curate